Catherine J. Kennedy

Also affiliated with Westmead Hospital, Westmead Institute for Medical Research, Cancer Council NSW

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 1%percentile

11.2Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Papers

Driven by 28 papers — median percentile 95. Top paper: “Pan-cancer analysis of whole genomes”.

Pan-cancer analysis of whole genomes

Nature(2020)10.1038/s41586-020-1969-6

Top 3%

5.9DataRank

Top 3%3307 citations

Lauri A. Aaltonen, Federico Abascal, Adam Abeshouse, Hiroyuki Aburatani, David J. Adams +1244 more

Analyses of non-coding somatic drivers in 2,658 cancer whole genomes

Nature(2020)10.1038/s41586-020-1965-x

Top 5%

4.6DataRank

Top 5%668 citations

Federico Abascal, Jeremiah A. Wala, Ofer Shapira, Grace Tiao, Henrik Hornshøj +1240 more

Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE)

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0103

N/A

1.8DataRank · unranked

76 citations

Joshy George, Chen Wang, Timothy Budden, Tuan Zea Tan, Derek S. Chiu +134 more

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Modern Pathology(2020)10.1038/s41379-020-0618-9

N/A

1.3DataRank · unranked

43 citations

Dane Cheasley, Cécile Le Page, Matthew J. Wakefield, Michelle da Cunha Torres, Simone M. Rowley +93 more

CCNE1 and survival of patients with tubo‐ovarian high‐grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study

Cancer(2022)10.1002/cncr.34582

N/A

1.2DataRank · unranked

46 citations

Ashley Weir, Nicola S. Meagher, Kyo Farrington, Gregg Nelson, Prafull Ghatage +95 more

p53 and ovarian carcinoma survival: an Ovarian Tumor Tissue Analysis consortium study

The Journal of Pathology Clinical Research(2023)10.1002/cjp2.311

Top 27%

0.751DataRank

Top 27%28 citations

Eunyoung Kang, Ashley Weir, Peter Rambau, Cheng‐Han Lee, Gregg Nelson +95 more

Prognostic gene expression signature for high-grade serous ovarian cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.05.019

N/A

0.718DataRank · unranked

119 citations

S. Chen, Blake Gilks, C. Wang, S.C.Y. Leung, V. Chow +387 more

Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1206

N/A

0.464DataRank · unranked

21 citations

Kylie L. Gorringe, Matthew J. Wakefield, Adelyn Bolithon, Chi Nam Ignatius Pang, Derek S. Chiu +95 more

Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study

British Journal of Cancer(2022)10.1038/s41416-022-02014-y

N/A

0.312DataRank · unranked

7 citations

Eunyoung Kang, Nicola S. Meagher, Gregg Nelson, Prafull Ghatage, Cheng‐Han Lee +88 more

Concurrent RB1 loss and BRCA -deficiency predicts enhanced immunological response and long-term survival in tubo-ovarian high-grade serous carcinoma

medRxiv(2023)10.1101/2023.11.09.23298321

N/A

0.269DataRank · unranked

5 citations

Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer +94 more

Author Correction: Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis

Communications Biology(2022)10.1038/s42003-022-03769-z

N/A

0.165DataRank · unranked

2 citations

Lars Feuerbach, Chen Hong, David Mas-Ponte, Randi Istrup Pedersen, PCAWG Drivers and Functional Interpretation Group +1255 more

Immunological and molecular features of the tumor microenvironment of long-term survivors of ovarian cancer

Journal of Clinical Investigation(2024)10.1172/jci179501

N/A

0DataRank · unranked

19 citations

Phineas T. Hamilton, Minh Tung Phung, Katy Milne, Bronwyn Harris, Shelby Thornton +73 more

Concurrent RB1 Loss and BRCA Deficiency Predicts Enhanced Immunologic Response and Long-term Survival in Tubo-ovarian High-grade Serous Carcinoma

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-3552

N/A

0DataRank · unranked

14 citations

Kazuaki Takahashi, Timothy Budden, Ahwan Pandey, Dinuka Ariyaratne, Tibor A. Zwimpfer +93 more

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk

medRxiv(2024)10.1101/2024.02.29.24303243

N/A

0DataRank · unranked

3 citations

Jonathan P. Tyrer, Joe Dennis, Goska Leslie, Manjeet K. Bolla, Michael Lush +95 more

Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.05.013

N/A

0DataRank · unranked

2 citations

Lauren Borho, Sarah E. Taylor, Linda E Kelemen, Anna deFazio, Penelope M. Webb +64 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA -deficient tubo-ovarian high-grade serous carcinoma

medRxiv(2025)10.1101/2025.09.17.25335919

N/A

0DataRank · unranked

0 citations

Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana, Laura Twomey +95 more

Beyond BRCA deficiency: Clinical and molecular predictors of survival in patients with BRCA-deficient tubo-ovarian high-grade serous carcinoma

Research Square(2025)10.21203/rs.3.rs-7572112/v1

N/A

0DataRank · unranked

0 citations

Tibor A. Zwimpfer, Sián Fereday, Ahwan Pandey, Dinuka Ariyaratne, Madawa Jayawardana +95 more

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

npj Genomic Medicine(2025)10.1038/s41525-025-00529-w

N/A

0DataRank · unranked

0 citations

Jonathan P. Tyrer, Joe Dennis, Goska Leslie, Manjeet K. Bolla, Michael Lush +95 more

Author Correction: Combined burden and functional impact tests for cancer driver discovery using DriverPower

Nature Communications(2022)10.1038/s41467-022-32343-8

N/A

0DataRank · unranked

0 citations

PCAWG Drivers and Functional Interpretation Working Group, Federico Abascal, Samirkumar B. Amin, Pratiti Bandopadhayay, Rameen Beroukhim +1242 more

Therapeutic options for mucinous ovarian carcinoma

Gynecologic Oncology(2020)10.1016/j.ygyno.2019.12.015

N/A

0DataRank · unranked

95 citations

Dane Cheasley, Matthew J. Wakefield, Georgina L. Ryland, Prue E. Allan, Kathryn Alsop +35 more

MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma

Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin(2021)10.1007/s00428-021-03232-0

N/A

0DataRank · unranked

23 citations

Joshua Millstein, Gordana Popović, Nicola S. Meagher, Adelyn Bolithon, Aline Talhouk +95 more

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer

Cancer Epidemiology Biomarkers & Prevention(2021)10.1158/1055-9965.epi-20-1817

N/A

0DataRank · unranked

13 citations

Karen McCue, Wei Shi, Sharon E. Johnatty, Jonathan Beesley, Andrew Civitarese +62 more

Prognostic and Immunological Significance of ARID1A Status in Endometriosis-Associated Ovarian Carcinoma

medRxiv(2021)10.1101/2021.09.16.21262993

N/A

0DataRank · unranked

4 citations

Tayyebeh M. Nazeran, Sandra Lee, Pauline Krämer, Evan S. Cairns, Derek S. Chiu +77 more

Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer.

Apollo (University of Cambridge)(2021)10.17863/cam.126709

N/A

0DataRank · unranked

0 citations

Karen McCue, Wei Shi, Sharon E. Johnatty, Jonathan Beesley, Andrew Civitarese +65 more

Molecular Subclasses of Clear Cell Ovarian Carcinoma and Their Impact on Disease Behavior and Outcomes

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3817

N/A

0DataRank · unranked

103 citations

Denise Chen, Rosario I. Corona, Zhuxuan Fu, Rajmohan Murali, Martin Köbel +33 more

Profiling the immune landscape in mucinous ovarian carcinoma

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.10.022

N/A

0DataRank · unranked

26 citations

Phineas T. Hamilton, Katy Milne, Shelby Thornton, Bronwyn Harris, Ashley Weir +40 more

Clinical parameters affecting survival outcomes in patients with low-grade serous ovarian carcinoma: an international multicentre analysis

Canadian Journal of Surgery(2023)10.1503/cjs.017020

N/A

0DataRank · unranked

5 citations

Marcus Q. Bernardini, Stéphanie Lheureux, Katja K.H. Aben, Elisa V. Bandera, Matthias W. Beckmann +42 more

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

The American Journal of Human Genetics(2024)10.1016/j.ajhg.2024.04.011

N/A

0DataRank · unranked

25 citations

Simon G. Coetzee, Jonathan P. Tyrer, Pei-Chen Peng, Will Rosenow, Stephanie Chen +95 more

Catherine J. Kennedy

Indexed papers

Top data-sharing exemplar

Papers